-
Signature
-
/s/ Jedidah Gold, as Attorney-in-Fact for Joseph Matheny
-
Issuer symbol
-
MCW
-
Transactions as of
-
13 Mar 2025
-
Net transactions value
-
-$5,117
-
Form type
-
4
-
Filing time
-
17 Mar 2025, 19:00:04 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
MCW |
Common Stock |
Options Exercise |
$396 |
+600 |
+0.71% |
$0.6600 |
85,495 |
13 Mar 2025 |
Direct |
|
| transaction |
MCW |
Common Stock |
Sale |
$4,782 |
-600 |
-0.7% |
$7.97 |
84,895 |
13 Mar 2025 |
Direct |
|
| transaction |
MCW |
Common Stock |
Options Exercise |
$66 |
+100 |
+0.12% |
$0.6600 |
84,995 |
14 Mar 2025 |
Direct |
|
| transaction |
MCW |
Common Stock |
Sale |
$797 |
-100 |
-0.12% |
$7.97 |
84,895 |
14 Mar 2025 |
Direct |
|
| holding |
MCW |
Common Stock |
|
|
|
|
|
45,000 |
13 Mar 2025 |
Emersyn Matheny Irrevocable Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
MCW |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-600 |
-0.4% |
$0.000000 |
148,008 |
13 Mar 2025 |
Common Stock |
600 |
$0.6600 |
Direct |
F1 |
| transaction |
MCW |
Stock Option (Right To Buy) |
Options Exercise |
$0 |
-100 |
-0.07% |
$0.000000 |
147,908 |
14 Mar 2025 |
Common Stock |
100 |
$0.6600 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: